Negative regulation of Odd-skipped related 2 by TGF-beta achieves the induction of cellular migration and the arrest of cell cycle

► TGF-β down-regulated Osr2 expression via Smad3/Smad4 and p38/ATF2 signaling molecules. ► Osr2 promoter possessed Smad3/4 and ATF2 binding elements. ► Osr2 reduced the level of cellular migration and stimulated cell-cycle progression. The transcription factor Odd-skipped related 2 (Osr2) functions...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 421; no. 4; pp. 696 - 700
Main Authors Kawai, Shinji, Amano, Atsuo
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 18.05.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:► TGF-β down-regulated Osr2 expression via Smad3/Smad4 and p38/ATF2 signaling molecules. ► Osr2 promoter possessed Smad3/4 and ATF2 binding elements. ► Osr2 reduced the level of cellular migration and stimulated cell-cycle progression. The transcription factor Odd-skipped related 2 (Osr2) functions in craniofacial and limb developments in mammals. We previously found that Osr2 gene expression is regulated by intracellular transcription factors such as Runx2, and C/EBP, whereas it remains unclear if extracellular factors would functionally regulate the Osr2 expression. In this study, we showed that TGF-β down-regulated the Osr2 expression, which is involved in regulation of cellular migration and cell cycle. Furthermore, the down-regulation was found to be mediated by Smad3/Smad4 and p38/ATF2 signaling molecules. The Osr2 promoter was shown to possess Smad3/4 binding element and ATF2 binding element between −647 and −64 of promoter. TGF-β induced cellular migration in C3H10T1/2 cells and arrested cell cycle at G1 phase in NMuMG-Fucci cells. In contrast, the Osr2 reduced the migration and also stimulated the cell-cycle progression. These results suggest that Osr2 is involved in TGF-β regulating cell migration and cell cycle via a Smad3-ATF2 transcriptional complex mediating pathway.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2012.04.064